CD4 and cancer: More recently, exogenous IL-21 was shown to inhibit the expression of FoxP3, the cardinal transcription factor associated with regulatory T cells, in human CD4+ T cells following encounter with cancer cells – in a manner similar to TGF-β blockade [28].